
NYSE:ARDT
This summary was created by AI, based on 4 opinions in the last 12 months.
Ardent Healthcare Partners Inc. (ARDT) has undergone a challenging period, marked by a significant 18% drop since being identified as a top pick earlier this year. Analysts at Stockchase highlight the company's expansion plans, including the addition of 18 urgent care clinics in 2025, which is a positive indicator for growth. The stock currently trades at attractive multiples with a price-to-earnings ratio of 7x and a book value of 1.5x, positioning it favorably with a return on equity of 25%. Despite recent struggles reflected in triggered stop-loss recommendations, there is a notable optimism about its earnings growth and productivity enhancements through AI and virtual nursing. Analysts have set price targets suggesting potential upside, but given the recent performance, caution is advised.
Ardent Healthcare Partners Inc. is a American stock, trading under the symbol ARDT (previously ARDT-N on Stockchase) on the New York Stock Exchange (ARDT). It is usually referred to as NYSE:ARDT or ARDT
In the last year, 5 stock analysts issued a Buy, Sell, or Hold rating on ARDT (previously ARDT-N on Stockchase). 5 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Ardent Healthcare Partners Inc..
Ardent Healthcare Partners Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2025-04-24. Read the latest stock experts ratings for Ardent Healthcare Partners Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Ardent Healthcare Partners Inc..
Ardent Healthcare Partners Inc. is followed by 12 investors on Stockchase and is a trending stock that is worth watching.
On 2026-07-02, Ardent Healthcare Partners Inc. (ARDT) stock closed at a price of $10.77.
Our PAST TOP PICK with ARDT has triggered its stop at $10.50. To remain disciplined, we recommend covering the position at this time. When combined with previous guidance, this will result in a net investment loss of 18%.